OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, India; Shanghai, China; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.
Funding
OrbiMed focuses on funding companies in the field of life sciences. The firm invests globally, with past investments on companies based in North America, Europe, and Asia (China, India, and Israel). The firm finances companies at various stages of development, from seed to buyouts. Its most recent funding round raised $551 million on September 2017.
Timeline
Funded Companies
Guardant HealthA biotechnology company developing precision oncology treatments.
Redwood City, California
Fusion PharmaceuticalsBiotechnology company using alpha particle emitting medical isotopes in targeted radiotherapy for cancer.
Hamilton, Ontario
Boston
Health CatalystA healthcare technology company offering a platform for organizing healthcare data from multiple systems.
Salt Lake City
Cyrus BiotechnologyBiotechnology software company offering protein modelling and design capabilities.
Seattle
Adicet BioAdicet Bio is a biotechnology company creating immune cell therapies for treating cancer and other diseases.
Menlo Park, California
BiomXBiomX is a biotechnology company developing phage therapies for eradicating bacteria associated with chronic diseases.
Ness Ziona
Constellation PharmaceuticalsA biopharmaceutical company dedicated to the development of novel therapeutics in the field of Epigenetics
Cambridge, Cambridgeshire
Cambridge, Massachusetts
ArsanisA company developing targeted monoclonal antibody immunotherapies for the treatment of infectious diseases
Vienna
KaNDy TherapeuticsKaNDy Therapeutics is a clinical-stage company focused on optimising the potential of NT-814 in the treatment of common, chronic debilitating female sex-hormone related conditions, with an initial focus on symptoms of the menopause.
Stevenage
Principia BioPharmaA biopharmaceutical company developing oral small molecule therapies for the treatment of cancer and autoimmune diseases
South San Francisco, California
Nested (company)Nested is a London-based company.
London
Enyo Pharma
France
Lyon
Alphamab Oncology
SpringWorks TherapeuticsSpringWorks Therapeutics is a Stamford, Connecticut-based company.
Stamford, Connecticut
Durham, North Carolina
MDCloneMDClone is an Israel-based company.
Israel
Alector
San Francisco
ZAI Lab
Shanghai
scPharmaceuticalsscPharmaceuticals is a Burlington, Massachusetts-based company.
Burlington, Massachusetts
Akeso BiopharmaAkeso Biopharma is a biotechnology company.
Guangdong
Fremont, California
Prevail TherapeuticsPrevail Therapeutics is a New York City-based company.
New York City
Galecto Biotech
Denmark
Armo Bio SciencesArmo Bio Sciences is a Redwood City, California-based company.
SmartZyme BioPharmaSmartZyme BioPharma is a New York City-based biotechnology company.
Edgewise TherapeuticsEdgewise Therapeutics is a Boulder, Colorado-based drug discovery company.
Boulder, Colorado
LogicBio TherapeuticsLogicBio Therapeutics is a Cambridge, Massachusetts-based company.
People
Carl Gordon
Managing Partner
Carter Neild
General Partner
Chau Knuong
Partner
David Wang
Partner
Geoffrey Hsu
General Partner
Jonathan Silverstein
Managing Partner
Jonathan Wang
Partner
Mathew Rizzo
Partner
Peter Thompson
Partner
Richard Klemm
Partner
Rishi Gupta
Partner
Scotland Stevens
General Partner
Scott Green
Partner
Sunny Sharma
Partner
Sven Borho
Managing Partner
Trevor Polischuk
Partner
William Sawyer
Partner
Further reading
Auto-extract from URL...
Documentaries, videos and podcasts
Auto-extract from URL...
Companies
Adaptimmune
Biopharmaceuticals
Adicet Bio
Biopharmaceuticals
Adimab
Biopharmaceuticals
Aeglea Biotherapeutics
Biopharmaceuticals
Aerpio
Biopharmaceuticals
Alector
Biopharmaceuticals
Alpine Immune Sciences
Biopharmaceuticals
Applied Immune Technologies
Biopharmaceuticals
Arrys Therapeutics
Biopharmaceuticals
Arsanis Biosciences
Biopharmaceuticals
Arvinas
Biopharmaceuticals
Ascendis Pharma
Atox Bio
Biopharmaceuticals
Attenua
Biopharmaceuticals
Audentes Therepeutics
Biopharmaceuticals
Avedro
Biopharmaceuticals
Avitide
Biopharmaceuticals
Baili Pharmaceutical
Biopharmaceuticals
Balance Therapeutics
Biopharmaceuticals
Bellus Health
Biopharmaceuticals
Bharat Serums and Vaccines
Biopharmaceuticals
BioLineRx
Biopharmaceuticals
CBT Pharmaceuticals
Biopharmaceuticals
ChemomAb
Biopharmaceuticals
Cleave Biosciences
Biopharmaceuticals
References
OrbiMed
Investor
CompanyCompany attributes
Venture capital
Microbiome
Mumbai
Herzliya
Hong KongCategories
Related Topics
Contributors
- 1
Dawson Sewell
Seeking to explain science and technology through simple writing. - 2
Khadidiatou Amirou
A knowledge enthusiast. - 3
Carla Faraguna
Golden People and Operations. - 4
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 5
Jude Gomila
Founder and CEO of Golden, Entrepreneur. Investor in 200+ companies. Cantabrigian (Gonville and Caius). Interested in the universe. - 6
Henry Ogolla
Passionate about reading and writing.